REFERENCES
- Kraemer KH, Lee MM, Scotto J. Xeroderma pigmento-sum: cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 1987; 123: 241–250.
- Cook BE Jr, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies. Ophthalmology 2001; 108: 2088–2098.
- Aurora A, Blodi F. Lesions of the eyelids. A clinico-pathologic study. Surv Ophthalmol 1970; 15: 94–104.
- Pinzi C, Campolmi P, Moretti S et al. Terapia fotodi-namica di tumori cutanei (non melanoma) primitivi e secondari con applicazione topica di acido 5-aminolevulinico. G Ital Dermatol Venereol 2001; 135: 427–31.
- Cappugi P, Campolmi P, Mavilia L, Prignano F, Rossi R. Topical 5-aminolevulinic acid and photodynamic therapy in dermatology: a minireview. J Chemother 2001; 13 (5): 494–502.
- Cappugi P, Rossi R. Terapia fotodinamica. In Laser e sorgenti luminose in dermatologia. Manuale di applicazioni pratiche di P. Campolmi, P. Bonan, G. Cannarozzo. Editore Masson. 2003: 131-148.
- Calzavara-Pinton PG, Procaccini EM, Cappugi P, Mavilia L, Rossi R, Monfrecola G. Terapia fotodinamica in dermatologia. In Fotodermatologia di P. Santoianni e G. Monfrecola. Edizioni CIC. 2003: 138–147.
- Peng Q, Warloe T, Berg K, et al. 5-aminolevulinic acid-based photodynamic therapy clinical research and future chal-lenges. Cancer 1997; 79: 2282-308.
- Gibson SL, Cupriks DJ, Havens JJ, Nguyen ML et al. A regulatory role for porphobilinogen deaminase (PBGD) in delta-aminolevulinic acid delta-ALA-induced photosensitiza-tion? Br J Cancer 1998; 77: 235–43.
- Moan J, Iani V, Ma LV. Choice of the proper wave-length for photochemotherapy. Proc SPIE 1996; 2625: 544–9.
- Szeimies RM, Abels C, Fritsch C, et al. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol 1995; 105: 672–7.
- Prignano F, Bianchi B, Domenici L, Rossi R, Romagnoli P, Pimpinelli N, Cappugi P, Giannotti B. Early apoptosis plays an important role in the healing mechanism of cutaneous basal cell carcinomas after photodynamic therapy. Br J Dermatol 2003; 149: 205–206.
- Donaldson MJ, Sullivan TJ, Whitehead KJ, Williamson RM. Squamous cell carcinoma of the eyelids. Br J Ophthalmol 2002; 86: 1161–1165.
- Cook BE Jr, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted Country, Minnesota. Ophthalmology 1999; 106: 746–750.
- Reifler DM, Hornblass A. Squamous cell carcinoma of the eyelid. Surv Ophthalmol 1986; 30: 349–365.
- Calzavara-Pinton PG, Zane C, Facchetti F et al. Terapia fotodinamica di neoplasie cutanee non-melanoma con applicazione locale di acido delta-aminolevulinico. G Ital Dermatol Venereol 1997; 132: 15–21.
- Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolevulinic acid as an appropriate approach to routine treatment of superficial non-melanoma skin cancer. J Photochem Photobiol B 1993; 18: 99–100.
- Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol 1998; 134: 207–14.
- Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389–413.